Browse All

Current Filters

CLEAR FILTER x

TITLE

Real-world Acute Treatment Optimization for Migraine with Ubrogepant: Results from the COURAGE II Study

Author:Nahas, Stephanie   Mays, Brittany   Naccara, Nicole   Wang, Cuiwei   Contreras-De Lama, Janette   Lipton, Richard   

Session Name:P8: Headache: Acute, Rescue, and Short-term Prevention Migraine Pharmacologic Treatment  

Topic:Headache  

Program Number:P8.015  

Author Institution:Thomas Jefferson University, Philadelphia, PA  University of Pennsylvania, PA  Abbvie, Chino Hills, CA  AbbVie, IL  Albert Einstein College of Medicine, Bronx, NY  

Reasons for Discontinuing Triptans Among Current Users of Rimegepant for the Acute Treatment of Migraine in the CONFIDENCE Study

Author:Hygge Blakeman, Karin   Urani, Alexandre   Lambru, Giorgio   Lipton, Richard   Goadsby, Peter   Pozo-Rosich, Patricia   Schwedt, Todd   Fanning, Kristina   Dai, Feng   Abraham, Lucy   

Session Name:P8: Headache: Acute, Rescue, and Short-term Prevention Migraine Pharmacologic Treatment  

Topic:Headache  

Program Number:P8.018  

Author Institution:Pfizer AB., Stockholm, Sweden  Aptar Digital Health, Paris, France  Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom  Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY  King’s College London, London, United Kingdom  Universitat Autònoma de Barcelona, Barcelona, Spain  Mayo Clinic, Phoenix, AZ  MIST Reserach, Wilmington, NC  Pfizer Inc., New York, NY  Pfizer R&D UK Ltd., Tadworth, United Kingdom  

Evaluation of Unmet Needs and Quality-of-Care Indicators among Patients with Migraine in the United States: 2021–2022

Author:Martin, Vincent   Ailani, Jessica   Parikh, Krutika   Deng, Huiwen   Dong, Yanan   Bodhani, Amit   Lipton, Richard   

Session Name:P9: Headache: Care Delivery, Education, Advocacy, and Equity  

Topic:Headache  

Program Number:P9.007  

Author Institution:University of Cincinnati Gardner Neuroscience Institute, Cincinnati, OH  Medstar Georgetown Neurology, McLean, VA  AbbVie, Inc., IL  AbbVie, Inc., North Chicago, IL  Albert Einstein College of Medicine, Bronx, NY  

Chronic Migraine Progression and Persistence: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study

Author:Lipton, Richard   Fanning, Kristina   Pozo-Rosich, Patricia   Brennan, K.C.   Burstein, Rami   Smith, Jonathan   Shakhmantsir, Iryna   Dabruzzo, Brett   Bostic, Ryan   Buse, Dawn   

Session Name:P9: Headache: Epidemiology 3  

Topic:Headache  

Program Number:P9.016  

Author Institution:Albert Einstein College of Medicine, Bronx, NY  MIST Reserach, Wilmington, NC  Vall d'Hebron University Hospital, Barcelona, Spain  University of Utah, Dept of Neurology, Salt Lake City, UT  Beth Isreal Deacones Medical Center, Boston, MA  AbbVie, Inc., Libertyville, IL  AbbVie, Inc., Boston, MA  AbbVie, Inc., Frederick, MD  MIST Research INC, Arden, NC  Albert Einstein College of Medicine, San Diego, CA